Facial injectable are products that contain
hyaluronic acid fillers, collagen fillers, and synthetic fillers for instance
calcium hydroxyl apatite. The use of these products like hyaluronic acid
enhances skin hydration, improves skin, and defends from Ultra Violet (UV)
damage & has relatively low side effects. It helps in rejuvenating facial
skin by raising scar depressions, reducing or eliminating wrinkles, and
enhancing lips.
According to study, “Worldwide
Facial Injectables Market Drivers, Opportunities, Trends, and Forecasts:
2017-2023” some of the major companies that are currently working in
the worldwide facial injectables market are Advanced Dermatology, Allergan Plc,
Merz Pharma GmbH & Co., Suneva Medical Inc., L.P., Fibrogen, Integra
Lifesciences, Valeant Pharmaceuticals International Inc., Sanofi SA, ColBar
LifeSciences Ltd., Ethicon, Merz Pharma GmbH & Co. KGaA, Tei BioSciences,
Medytox Inc., Ankita Therapeutics Inc., Teoxane SA, Galderma S.A., KGaA, Nestle
Skin Health (Galderma Pharma SA), Sinclair Pharma Plc, Ipsen S.A., Bloomage
Biotechnology Corp. Ltd. All these key vendors are adopting partnerships and
product launches policies in order to address the unmet aesthetic requirements
thereby, offering physicians with new & better options.
Based on type, worldwide facial injectable
market is segmented into dermal fillers or injectable implants and wrinkle
relaxers. Dermal fillers include collagen, hyaluronic acid, calcium
hydroxylapatite, fat injection, Polymethyl-methacrylate microspheres (PMMA), polylactic
acid and others (polyalkylimide). Wrinkle relaxers include dysport, botox and
xeomin. Based on product type, market is segmented into Restylane-Hyaluronic
Acid-Based Filler, PREVELLE Silk-Hyaluronic Acid-Based Filler,
Juvederm-Hyaluronic Acid-Based Filler, Belotero-Hyaluronic Acid-Based Filler,
Hydrelle-Hyaluronic Acid-Based Filler, Evolence-Collagen-Based Fillers,
Cosmoplast-Collagen-Based Fillers, Radiesse-Semi-Permanent Fillers,
Sculptra-Semi-Permanent Fillers, BOTOX-OnabotulinumtoxinA, ArteFill-Permanent
Fillers, Xeomin-IncobotulinumtoxinA, Dysport-AbobotulinumtoxinA,
Myobloc-RimabotulinumtoxinB. Furthermore, the other applications include lip
augmentation, lipoatrophy treatment, face lift, facial line correction and
others (earlobe rejuvenation & chin augmentation). Additionally, based on
end-users, market is segmented into beauty clinics, hospitals, dermatology
research institutes and dermatology clinics.
The International Society of Aesthetic Plastic
Surgery (ISAPS) is an association for board-specialized aesthetic plastic
surgeons, dedicated to encouraged related to excellence in the field of
aesthetic plastic surgery worldwide. The Society recommends symposia,
instructional courses, and educational courses, while the members of ISAPS have
entrance to the most advanced techniques such as dermal fillers and botulinum
toxin. Furthermore, the American Academy of Facial Esthetics (AAFE) aims to
give information about non-invasive and non-surgical facial injectable
techniques to healthcare experts globally. AAFE is also devoted to providing
the most excellent possible outcomes in areas of facial pain treatment and
facial esthetics.
The worldwide facial injectable market is
driven by the introduction of cost-effective facial injectables with the increase
in aging population, growing awareness about facial injections, and rising
aesthetic consciousness leading to increase in cosmetic procedures. Apart from
profits, some of the major restraints leading to reimbursement policies
supporting cosmetic procedures, followed by presence of counterfeit products
& unregistered practitioners and side-effects of available products are
impacting the market growth substantially. The worldwide facial market is
witnessing the rise in trends in medical tourism and increase in demand for
combination treatments etc.
North America being the leader in the global
facial injectables market increasing the emphasis about physical appearance and
increasing awareness on the advanced beauty treatments. In 2017, approximately
2 million women in U.S. have undergone an aesthetic injectable procedures,
while approximately 17 million were considered to be aesthetic injectable cure,
leading to growing demand for facial injectable.
For more information, click on the
link below:
Contact Us:
Ken Research
Ankur
Gupta, Head Marketing & Communications
+91
9015378249